James Swetech, MD
Gastroenterology · Brownstown Twp, MINPI 1336189232
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (58.8%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Salix Pharmaceuticals, A Division Of Bausch Health US, LLC accounts for 63.4% of it on its own, with 32 other manufacturers making up the rest. Reporting peaked in 2019 at $19,245 and has fallen 67.4% since, to $6,283 in 2025. Among gastroenterology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 559 payments — averaging $94.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$33K
- Romark Laboratories, LC$4K
- Johnson & Johnson$3K
- Ipsen Biopharmaceuticals, Inc$3K
- AbbVie$2K
- Madrigal Pharmaceuticals$1K
- plus $6K from 27 others
What the payments were for
- Consulting fees$3,8757%
- Speaking & faculty fees$31,00059%
- Travel & lodging$1,1832%
- Food & beverage$16,60031%
- Education$770%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 229 | $33,453 |
| Romark Laboratories, LC | 17 | $4,398 |
| Johnson & Johnson(2 entities) | 38 | $2,775 |
| Ipsen Biopharmaceuticals, Inc | 8 | $2,657 |
| AbbVie(2 entities) | 77 | $2,272 |
| Madrigal Pharmaceuticals | 19 | $1,027 |
| Gilead | 29 | $885 |
| Takeda Pharmaceuticals U.S.A., Inc. | 38 | $864 |
| Ardelyx, Inc. | 29 | $689 |
| Medtronic | 4 | $501 |
| Intercept Pharmaceuticals, Inc. | 15 | $473 |
| Ambu Inc. | 5 | $335 |
| Phathom Pharmaceuticals, Inc. | 9 | $288 |
| Lilly USA, LLC | 4 | $178 |
| Daiichi Sankyo Inc. | 5 | $163 |
| AstraZeneca | 2 | $138 |
| ERBE USA Inc | 1 | $136 |
| Janssen Scientific Affairs, LLC | 1 | $132 |
| QOL Medical, LLC | 2 | $131 |
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| Sanofi | 1 | $125 |
| Olympus America Inc. | 1 | $125 |
| Pentax Of America, Inc. | 1 | $118 |
| Aimmune Therapeutics, Inc. | 4 | $117 |
| Novo Nordisk | 2 | $114 |
| Bristol Myers Squibb | 5 | $90 |
| Merit Medical Systems Inc | 1 | $86 |
| Capsovision, Inc. | 2 | $80 |
| Cook Medical LLC | 1 | $79 |
| Eisai Inc. | 1 | $75 |
| Shionogi Inc | 3 | $50 |
| Pfizer | 2 | $33 |
| Nestle Healthcare Nutrition Inc. | 2 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$52,735 in reported general payments places this provider in the 95th percentile of 497 gastroenterology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 46 | $43,693 |
| Sucralfate | 90 | $16,821 |
| Pantoprazole Sodium | 358 | $9,706 |
| Mesalamine | 16 | $9,644 |
| TrulancePlecanatide | 11 | $7,916 |
| Colestipol Hcl | 70 | $5,594 |
| Famotidine | 239 | $5,475 |
| Dicyclomine Hcl | 145 | $3,267 |
| Mesalamine ErMesalamine | 11 | $3,175 |
| Ursodiol | 18 | $2,664 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 62 | $2,514 |
| Lactulose | 92 | $2,506 |
| Omeprazole | 101 | $2,472 |
| Ondansetron OdtOndansetron | 53 | $1,515 |
| Esomeprazole Magnesium | 13 | $728 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $2,272 | $43,69346 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $33,453 | $7,91611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 497 gastroenterology providers in Michigan.
Other gastroenterology in Brownstown Twp
- Kimberly BrownDetroit$733K
- Dilip MoonkaDetroit$611K
- Philip SchoenfeldAnn Arbor$539K
- Michelle Muza-MoonsAnn Arbor$481K
- Partha NandiTroy$377K
- Bradford WhitmerSaint Clair Shores$206K
- Mohammed BarawiSt Clair Shores$193K
- Stuart GordonDetroit$178K
- Mohamad AlsibaeRoyal Oak$127K
- Allison SchulmanAnn Arbor$124K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.